Market Indices
Sector Heatmap
EVMN — Evommune, Inc.
NYSEEvommune, Inc.
- O
- 7.25
- H
- 7.28
- L
- 6.74
- V
- 1.74M
EVMN — Latest News & Headlines
11 StoriesEvommune (NYSE:EVMN) - Stock Analysis - Simply Wall Street
Evommune (NYSE:EVMN) - Stock Analysis Simply Wall Street
$EVMN stock is down 8% today. Here's what we see in our data. - quiverquant.com
$EVMN stock is down 8% today. Here's what we see in our data. quiverquant.com
This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism? - Stocktwits
This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism? Stocktwits
Evommune to present Phase 2a atopic dermatitis data | EVMN Stock News - stocktitan.net
Evommune to present Phase 2a atopic dermatitis data | EVMN Stock News stocktitan.net
Evommune, Inc. (NYSE:EVMN) Stock Has Average Target Price of $33.33 According to Analysts - MarketBeat
Evommune, Inc. (NYSE:EVMN) Stock Has Average Target Price of $33.33 According to Analysts MarketBeat
Evommune: Pipeline Reset After EVO756 Failure, All Eyes On EVO301 (NYSE:EVMN) - Seeking Alpha
Evommune: Pipeline Reset After EVO756 Failure, All Eyes On EVO301 (NYSE:EVMN) Seeking Alpha
After two doses, patients’ eczema responses kept improving for eight weeks. - stocktitan.net
After two doses, patients’ eczema responses kept improving for eight weeks. stocktitan.net
Evommune (EVMN) Edges Higher: Shares Gain 1.59% to $9.60 as Buyers Hold Support - Total Put Call - dars.gov.et
Evommune (EVMN) Edges Higher: Shares Gain 1.59% to $9.60 as Buyers Hold Support - Total Put Call dars.gov.et
Evommune (EVMN) Edges Higher: Shares Gain 1.59% to $9.60 as Buyers Hold Support - Keltner Channel - dars.gov.et
Evommune (EVMN) Edges Higher: Shares Gain 1.59% to $9.60 as Buyers Hold Support - Keltner Channel dars.gov.et
Evommune (EVMN) Edges Higher: Shares Gain 1.59% to $9.60 as Buyers Hold Support - AAII Bearish - dars.gov.et
Evommune (EVMN) Edges Higher: Shares Gain 1.59% to $9.60 as Buyers Hold Support - AAII Bearish dars.gov.et
Evommune announces positive Phase 2a results for EVO301 - TipRanks
Evommune announces positive Phase 2a results for EVO301 TipRanks